J&J, DePuy To Face Partly Revived FCA Suit Over Hip Device
By Melissa Daniels (July 26, 2017, 10:09 PM EDT) -- A First Circuit panel on Wednesday partially revived claims against Johnson & Johnson and its subsidiary DePuy Orthopaedics Inc. in a False Claims Act suit filed by two whistleblower physicians over allegedly defective hip replacement devices.
The panel agreed with a lower court's decision to dismiss parts of the complaint that accused the companies of making false statements to the FDA over its marketing of a hip replacement device. But it revived claims connected to accusations that DePuy caused physicians to seek government reimbursement for devices that didn't match the FDA-approved designs, saying the claims were properly pled.
The panel said...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!